Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinib
2011
Based on the impressive results from the IRIS trial (International Randomized Interferon vs. STI-571), the tyrosine kinase inhibitor (TKI) imatinib mesylate (IM) has become the recommended first-li...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
14
References
0
Citations
NaN
KQI